CN101912524B - Schisandra liver-benefiting capsules - Google Patents
Schisandra liver-benefiting capsules Download PDFInfo
- Publication number
- CN101912524B CN101912524B CN2010102580978A CN201010258097A CN101912524B CN 101912524 B CN101912524 B CN 101912524B CN 2010102580978 A CN2010102580978 A CN 2010102580978A CN 201010258097 A CN201010258097 A CN 201010258097A CN 101912524 B CN101912524 B CN 101912524B
- Authority
- CN
- China
- Prior art keywords
- hepatitis
- virus
- liver
- radix
- schisandra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses schisandra liver-benefiting capsules, which relates to a Chinese patent medicament, in particular to a capsule preparation for oral administration for treating hepatitis B virus carriers and hepatitis symptoms caused by the hepatitis B virus carriers such as jaundice and transaminase rise. The invention provides the capsule preparation for bilirubin caused by the hepatitis B virus carriers. The capsule preparation for bilirubin abnormality, glutamic-pyruvic transaminase abnormality, glutamic-oxalacetic transaminase abnormality and r-glutamyl transpeptidase abnormality caused by the hepatitis B virus carriers has the characteristics of low treatment cost, low dose, no toxic or side effect and quick enzyme drop, has high negative conversion ratio of hepatitis B virus, and has no phenomena of rebound, medicament resistance and virus variation after medicament stop. The schisandra liver-benefiting capsules have the effects of removing dampness and relieving toxin, inhibiting and clearing the hepatitis B virus, soothing the liver and breaking blood stasis, promoting qi circulation and relieving depression, tonifying spleen and removing retention, tonifying qi, warming channels, stimulating qi and blood and strengthening the body resistance to eliminate pathogenic factors by using the traditional Chinese medicament theory. The schisandra liver-benefiting capsules have the advantages of accurate curative effect, convenient administration, safety and reliability.
Description
Technical field: the present invention relates to traditional Chinese medical science patent medicine, especially oral medication hepatitis B virus carriers and the hepatitis symptom that causes thereof are as jaundice, transaminase rising person's capsule preparations.
Background technology: for the hepatitis B viruses (HBV) carrier, at present international and domestic still do not have any therapy or any medicine can definitely be cured.For drug resistance that solves hepatitis B virus and host's immunologic tolerance itself, no matter in academia and the clinical blank that still belongs to.The lamivudine that international and domestic hepatopathy expert approves, the sweet analog of nuclear such as Entecavir has produced corresponding side effect, and some cases have confirmed this point.The virus YMDD variation of taking lamivudine for a long time and producing, upgrading Drug therapy to next step more increases difficulty.
Summary of the invention: the present invention's " schisandra liver-benefiting capsules " content is the traditional theory of Chinese medical science of utilization, select prescription compatibilities such as Fructus Schisandrae Chinensis, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Radix Sophorae Flavescentis, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Radix Bupleuri, Radix Ophiopogonis, Radix Ginseng, Flos Lonicerae, Radix Scutellariae, Rhizoma Coptidis, Rhizoma Alismatis, Semen Plantaginis, Herba Hedyotidis Diffusae, Scorpio, Scolopendra for use, make powder through pulverizing after mixing sieves, incapsulate.Prescription compatibility of the present invention is simple, making is easy, only need be oral during use, and the bilirubin that hepatitis B virus carriers is caused is unusual, glutamate pyruvate transaminase, glutamic oxaloacetic transaminase, GOT, r-glutamyl transpeptidase are unusual, have the treatment cost low, consumption is little, has no side effect, and falls the fast characteristics of enzyme.And, there are not knock-on, no drug resistance, no variation phenomenon after the drug withdrawal to hepatitis B virus converting negative rate height.Wherein Radix Sophorae Flavescentis, Rhizoma Polygoni Cuspidati, Radix Scutellariae, Flos Lonicerae, Rhizoma Coptidis have the damp eliminating detoxifcation, suppress and remove the function of hepatitis B virus, and Fructus Schisandrae Chinensis has the enzyme of falling, the turbid descending and holds back liver function.Herba Artemisiae Scopariae, Radix Bupleuri have soothing liver-QI for relieving depression, fall the jaundice function.The Radix Astragali, Radix Ginseng, Herba Epimedii strongly invigorating primordial QI, vital energy benefiting and the kidney invigorating, rouses oneself QI and blood, strengthening vital QI to eliminate pathogenic factors at promoting the flow of QI-blood by warming the meridian.And have and improve T lymphocyte phagocytic function, human body immunity improving power.All medicines are harmonious, and become heat-clearing and toxic substances removing altogether, remove the agent of hepatitis B virus.Chronic disease has cold and heat to tie mutually more, and deficiency and excess is also seen symptom, hepatitis B patient especially with damp-heat virus for very, the stagnation of liver-QI blood stasis, spleen kidney two loses, battalion defends diagonosis of disorder, its pathogeny it is considered herein that lowly relevant with immune response and immunoloregulation function.When a hepatitis B patient under unwitting situation, live in infected patient among the group and belong to the people of above type substantially,, improve the human body resistance against diseases so the present invention's large dose Astragalis, Radix Ginseng etc. strengthen immune function of human body, impel QI and blood full, just winning heresy and dispelling.
The specific embodiment: the invention will be further described below in conjunction with specific embodiment: select for use Fructus Schisandrae Chinensis 25g, Radix Astragali 25g, Radix Ginseng 20g, Herba Epimedii 15g, Radix Bupleuri 10g, Radix Ophiopogonis 10g, Herba Artemisiae Scopariae 25g, Radix Salviae Miltiorrhizae 15g, Radix Sophorae Flavescentis 25g, Rhizoma Polygoni Cuspidati 25g, Radix Scutellariae 20g, Flos Lonicerae 20g, Rhizoma Coptidis 15g, Herba Hedyotidis Diffusae 20g, Rhizoma Alismatis 20g, Semen Plantaginis 20g, 18 flavor Chinese medicines such as Scorpio 6g, Scolopendra 6g to adorn the 1# capsule after selected drying and crushing is crossed 100 mesh sieves, every clothes 4-5 grain, the morning, noon and afternoon are warm water delivery service after meal.The present invention's " schisandra liver-benefiting capsules " damp eliminating detoxifcation suppresses and removes hepatitis B virus, and soothing the liver removing blood stasis with potent drugs, promoting QI circulation for relieving depression, spleen invigorating removing food stagnancy, invigorating vital QI, promoting the flow of QI-blood by warming the meridian, rouses oneself QI and blood, strengthening vital QI to eliminate pathogenic factors.Simultaneously dead stroke, do not recur, how medicine, virus do not make a variation, determined curative effect, taking convenience, safe and reliable.
Case: patient Zhang, the woman, 38 years old, through looking into the hepatitis B great three positive, glutamate pyruvate transaminase 225, glutamate-oxaloacetate transaminase 10. total subcutaneous ulcer red pigments 33, through the clothes schisandra liver-benefiting capsules after January, millet straw, glutamate pyruvate transaminase, total subcutaneous ulcer red pigment are normal, decrement continue clothes after March HBV-DNA normal again.
Patient marquis, the woman, 33 years old, abnormal liver function index before the treatment: total bilirubin 90, glutamate pyruvate transaminase 200, glutamate-oxaloacetate transaminase 21 was taken schisandra liver-benefiting capsules after two months, and is existing normal substantially.
The patient poplar, the man, 35 years old, abnormal liver function index before the treatment: total bilirubin 50, glutamate pyruvate transaminase 175, glutamate-oxaloacetate transaminase 05 is after taking the schisandra liver-benefiting capsules one and a half months, normal substantially.
Claims (1)
1. treat the start an inflammation of the liver capsule preparations of symptom of hepatitis B virus carriers and hepatitis B virus thereof for one kind.
It is characterized in that prescription compatibility weight ratio is: Fructus Schisandrae Chinensis 25g, Radix Astragali 25g, Radix Ginseng 20g, Herba Epimedii 15g, Radix Bupleuri 10g, Radix Ophiopogonis 10g, Herba Artemisiae Scopariae 25g, Radix Salviae Miltiorrhizae 15g, Radix Sophorae Flavescentis 25g, Rhizoma Polygoni Cuspidati 25g, Radix Scutellariae 20g, Flos Lonicerae 20g, Rhizoma Coptidis 15g, Herba Hedyotidis Diffusae 20g, Rhizoma Alismatis 20g, Semen Plantaginis 20g, Scorpio 6g, Scolopendra 6g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102580978A CN101912524B (en) | 2010-08-15 | 2010-08-15 | Schisandra liver-benefiting capsules |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102580978A CN101912524B (en) | 2010-08-15 | 2010-08-15 | Schisandra liver-benefiting capsules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101912524A CN101912524A (en) | 2010-12-15 |
| CN101912524B true CN101912524B (en) | 2011-09-28 |
Family
ID=43320271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102580978A Expired - Fee Related CN101912524B (en) | 2010-08-15 | 2010-08-15 | Schisandra liver-benefiting capsules |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101912524B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102114182B (en) * | 2011-02-18 | 2012-05-30 | 海南师范大学 | Compound preparation for resisting heat stress and heat fatigue |
| CN109091611B (en) * | 2012-08-09 | 2021-06-08 | 石家庄以岭药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for treating liver dysfunction caused by hepatitis |
| CN103071083A (en) * | 2012-12-04 | 2013-05-01 | 陈柏林 | Traditional Chinese medicine composition for treating hepatitis B |
| CN103893566A (en) * | 2014-03-31 | 2014-07-02 | 张家界金鲵生物工程股份有限公司 | Giant salamander Chinese herbal medicine compound preparation for treating hepatitis B |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1698812A (en) * | 2005-06-07 | 2005-11-23 | 龚禹铭 | Pharmaceutical composition for treating hepatitis B |
-
2010
- 2010-08-15 CN CN2010102580978A patent/CN101912524B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101912524A (en) | 2010-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102423421A (en) | Medicine for treating hypertension | |
| CN102188560A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN101204497A (en) | Peroral Chinese traditional medicine for aplastic anemia | |
| CN101912524B (en) | Schisandra liver-benefiting capsules | |
| CN102423442B (en) | Double-component medicine for treating fatty liver and preparation method thereof | |
| CN101695566A (en) | Chinese medicament for treating cephalagra | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN102406834A (en) | Medicament for treating Yang deficiency of women menopause syndrome | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN101856487A (en) | Chinese medicament for treating insomnia | |
| CN102000273A (en) | Tea, granules, capsules and oral liquid for resisting fatigue and preventing and treating urinary tract infection | |
| CN101357184A (en) | Chinese traditional medicine for treating hepatosis and preparation method thereof | |
| CN1232288C (en) | Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process | |
| CN101468188A (en) | Health-care medicament for treating hypertension | |
| CN100998825A (en) | Oral Chinese medicine for treating yin blood insufficiency type virus myocarditis | |
| CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN103028076B (en) | Traditional Chinese medicine composition for treating liver cirrhosis | |
| CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN1451413A (en) | Flavoured siberian solomonseal rhizome decoction and preparing process thereof | |
| CN102406906A (en) | Traditional Chinese medicine composition for treating acute hepatitis B | |
| CN102293921A (en) | Traditional Chinese medicine composition for treating deafness | |
| CN100998720B (en) | Oral traditional Chinese medicine for treating amenorrhea of uterus stasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20120815 |